Entropion Treatment Market Share

  • Report ID: 3777
  • Published Date: Aug 05, 2024
  • Report Format: PDF, PPT

Entropion Treatment Market Share

North American Market Forecast   

The North American entropion treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the rising cases of entropion in older adults and higher number of people suffering with dry eye issues. According to the American Academy of Ophthalmology, the prevalence of entropion increases with the age, it increased by around 1% for patients aged 60 to 69, nearly 2% for those aged 70 to 79, and around 8% for those above the age of 80. Moreover, in America, between 16 and 49 million people have dry eyes, which accounts for 15% of the population.

APAC Market Statistics

The Asia Pacific entropion treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market in the region is credited to large geriatric population in countries that increase the chances of entropion patients in the region, such as India and China. According to the data by the World Bank, the population above 65 years of age in India crossed 90,719,952 in 2020, while, it crossed 167,808,567 in China. 

Research Nester
Entropion-Treatment-Market-regional
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3777
  • Published Date: Aug 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of entropion treatment is evaluated at USD 456.14 Million.

The entropion treatment market size was over USD 427.5 Million in 2023 and is projected to exceed USD 993.28 Million by 2036, witnessing over 6.7% CAGR during the forecast period i.e., between 2024-2036. Increasing geriatric population, rising success of the entropion treatment, the growing popularity of contact lenses, and increasing cases of dry eye syndrome are driving the market growth.

North America industry is expected to account for largest revenue share by 2036, due to rising cases of entropion in older adults, and higher number of people suffering with dry eye issues.

The major players in the market are Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample